Ondansetron - a promising adjunctive treatment for persistent schizophrenia

firemonkey · October 26, 2018, 12:24pm

ncbi.nlm.nih.gov

Ondansetron - a promising adjunctive treatment for persistent schizophrenia.

J Kulkarni, N Thomas, AR Hudaib, E Gavrilidis and C Gurvich, Journal of psychopharmacology (Oxford, England), Oct 25 2018

Ondansetron is a serotonin 3 receptor antagonist widely used to prevent nausea and vomiting in pregnancy and in patients receiving chemotherapy. There is growing evidence that adjunctive ondansetron treatment improves symptomatology associated with schizophrenia, particularly with respect to the positive, negative and cognitive symptoms. Further studies that are applicable to real world practice are required to assess the efficacy and effectiveness of this treatment, which could be readily and rapidly translated into clinical practice.This randomized control trial compared adjunctive (8 mg/daily) ondansetron or placebo to commonly prescribed atypical antipsychotics for people suffering with chronic schizophrenia ( ClinicalTrials.gov NCT01121042).The study involved 85 outpatients aged 18-65 years with a diagnosis of schizophrenia or schizoaffective disorder who participated in a two-arm randomized control trial.Longitudinal analyses revealed adjunctive ondansetron provided significant improvement in the cognitive domain ( p<0.05) as measured by the Positive and Negative Syndrome Scale between baseline and week 12. The analysis of "Combination" showed ondansetron effect on Total Positive and Negative Syndrome Scale, approaching significance by week 12 ( p=0.06). No group differences were obtained in the Montgomery-Asberg Depression Rating Scale or Positive and Negative Syndrome Scale subscales.This treatment trial provides some support for adjunctive ondansetron medication as a treatment for the cognitive disorganization symptoms of schizophrenia.

twinklestars · October 26, 2018, 5:01pm

I guess if they can give it to pregnant women, it has to be relatively safe.

Topic		Replies	Views
Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials News	0	239	March 18, 2019
Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial News	8	964	March 16, 2017
Safety and Efficacy of Ondansetron and Simvastatin as Potential Adjunctive News	4	402	June 17, 2023
Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin News	0	18	September 5, 2024
Zofran against negative symptoms & tardive dyskinesia Medications	2	1777	February 19, 2016

Ondansetron - a promising adjunctive treatment for persistent schizophrenia

Related topics